HLA Demographics Study in Adults With Type 1 Diabetes
ConditionDiabetes Mellitus, Type I
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-55
SponsorGentiBio, Inc
About this trial
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Eligibility criteria
Qualifiers
Fasting glucose ≥ 126 mg/dL (7.0 mmol/L), or
2-hour oral glucose tolerance test plasma glucose ≥ 200 mg/dL (11.0 mmol/L), or
Hemoglobin A1c ≥ 6.5%, or
Random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) (with documented classic hyperglycemia symptoms or hyperglycemic crisis).
Disqualifiers
Participant is an employee of, or an immediate family member of an employee, of the Sponsor, study site, or of a contractor/vendor who is involved in direct study conduct for this protocol.
Participant is unwilling or unable to comply with the study visit assessments.
Trial design
Treatments tested in this trial
- blood draw or cheek swab
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov